| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 肠外营养系(元) | 615,221,192.95 | 277,443,433.40 | 641,475,102.78 | 290,664,735.25 |
| 肝胆消化(元) | 67,002,251.58 | 30,799,629.01 | 65,812,991.66 | 25,031,513.64 |
| 抗生素(元) | 118,896,746.80 | 49,933,797.25 | 98,152,616.35 | 47,265,094.76 |
| 麻醉产品(元) | 849,666,633.50 | 342,656,667.79 | 437,175,555.36 | 128,957,335.04 |
| 市场推广(元) | - | - | 277,833,360.30 | 95,197,017.55 |
| 心脑血管(元) | 67,488,953.83 | 26,627,878.79 | 89,445,040.70 | 39,294,153.18 |
| 原料药及专利技术(元) | - | - | 750,335,658.89 | 331,502,820.70 |
| 肿瘤止吐(元) | 211,715,078.81 | 67,553,855.10 | 265,771,854.57 | 116,350,753.00 |
| 服务收入(元) | 413,766,347.53 | 133,050,937.59 | - | - |
| 原料药(元) | 569,779,722.75 | 237,589,188.65 | - | - |
| 其他主营业务(元) | - | - | - | 165,205,266.64 |
| 其他业务(元) | - | - | - | 7,877,866.54 |
| 其他产品(元) | 421,596,915.82 | 194,927,930.96 | 372,261,146.94 | 165,205,266.64 |
| 营业成本(元) | ||||
| 肠外营养系(元) | 241,248,829.07 | 105,601,302.58 | 220,213,900.95 | 100,708,811.47 |
| 肝胆消化(元) | 30,001,215.01 | 9,269,168.29 | 19,809,002.39 | 8,018,700.44 |
| 抗生素(元) | 30,172,493.44 | 11,456,656.58 | 25,676,024.74 | 13,046,631.47 |
| 麻醉产品(元) | 85,497,718.34 | 19,851,799.91 | 34,342,406.86 | 12,574,292.80 |
| 市场推广(元) | - | - | 262,481,544.31 | 90,336,286.84 |
| 心脑血管(元) | 23,563,760.27 | 6,614,297.76 | 20,823,912.35 | 9,038,082.80 |
| 原料药及专利技术(元) | - | - | 207,629,725.63 | 90,377,824.61 |
| 肿瘤止吐(元) | 33,878,809.42 | 10,046,846.22 | 39,920,371.16 | 25,269,726.65 |
| 服务收入(元) | 167,676,015.77 | 63,678,503.17 | - | - |
| 原料药(元) | 210,936,630.49 | 115,165,286.93 | - | - |
| 其他主营业务(元) | - | - | - | 30,477,852.44 |
| 其他业务(元) | - | - | - | 7,736,368.92 |
| 其他产品(元) | 136,240,289.65 | 45,488,826.99 | 73,045,338.45 | 30,477,852.44 |
| 毛利(元) | ||||
| 肠外营养系(元) | 373,972,363.88 | 171,842,130.82 | 421,261,201.83 | 189,955,923.78 |
| 肝胆消化(元) | 37,001,036.57 | 21,530,460.72 | 46,003,989.27 | 17,012,813.20 |
| 抗生素(元) | 88,724,253.36 | 38,477,140.67 | 72,476,591.61 | 34,218,463.29 |
| 麻醉产品(元) | 764,168,915.16 | 322,804,867.88 | 402,833,148.50 | 116,383,042.24 |
| 市场推广(元) | - | - | 15,351,815.99 | 4,860,730.71 |
| 心脑血管(元) | 43,925,193.56 | 20,013,581.03 | 68,621,128.35 | 30,256,070.38 |
| 原料药及专利技术(元) | - | - | 542,705,933.26 | 241,124,996.09 |
| 肿瘤止吐(元) | 177,836,269.39 | 57,507,008.88 | 225,851,483.41 | 91,081,026.35 |
| 服务收入(元) | 246,090,331.76 | 69,372,434.42 | - | - |
| 原料药(元) | 358,843,092.26 | 122,423,901.72 | - | - |
| 其他主营业务(元) | - | - | - | 134,727,414.20 |
| 其他业务(元) | - | - | - | 141,497.62 |
| 其他产品(元) | 285,356,626.17 | 149,439,103.97 | 299,215,808.49 | 134,727,414.20 |
| 毛利率(%) | ||||
| 肠外营养系(%) | 60.79 | 61.94 | 65.67 | 65.35 |
| 肝胆消化(%) | 55.22 | 69.90 | 69.90 | 67.97 |
| 抗生素(%) | 74.62 | 77.06 | 73.84 | 72.40 |
| 麻醉产品(%) | 89.94 | 94.21 | 92.14 | 90.25 |
| 市场推广(%) | - | - | 5.53 | 5.11 |
| 心脑血管(%) | 65.09 | 75.16 | 76.72 | 77.00 |
| 原料药及专利技术(%) | - | - | 72.33 | 72.74 |
| 肿瘤止吐(%) | 84.00 | 85.13 | 84.98 | 78.28 |
| 服务收入(%) | 59.48 | 52.14 | - | - |
| 原料药(%) | 62.98 | 51.53 | - | - |
| 其他主营业务(%) | - | - | - | 81.55 |
| 其他业务(%) | - | - | - | 1.80 |
| 其他产品(%) | 67.68 | 76.66 | 80.38 | 81.55 |
| 收入构成(%) | ||||
| 肠外营养系(%) | 18.45 | 20.39 | 21.39 | 20.58 |
| 肝胆消化(%) | 2.01 | 2.26 | 2.20 | 1.77 |
| 抗生素(%) | 3.56 | 3.67 | 3.27 | 3.35 |
| 麻醉产品(%) | 25.48 | 25.18 | 14.58 | 9.13 |
| 市场推广(%) | - | - | 9.27 | 6.74 |
| 心脑血管(%) | 2.02 | 1.96 | 2.98 | 2.78 |
| 原料药及专利技术(%) | - | - | 25.03 | 23.47 |
| 肿瘤止吐(%) | 6.35 | 4.97 | 8.86 | 8.24 |
| 服务收入(%) | 12.41 | 9.78 | - | - |
| 原料药(%) | 17.08 | 17.46 | - | - |
| 其他主营业务(%) | - | - | - | 11.70 |
| 其他业务(%) | - | - | - | 0.56 |
| 其他产品(%) | 12.64 | 14.33 | 12.42 | 11.70 |
| 毛利构成(%) | ||||
| 肠外营养系(%) | 15.74 | 17.65 | 20.11 | 19.10 |
| 肝胆消化(%) | 1.56 | 2.21 | 2.20 | 1.71 |
| 抗生素(%) | 3.73 | 3.95 | 3.46 | 3.44 |
| 麻醉产品(%) | 32.16 | 33.16 | 19.23 | 11.70 |
| 市场推广(%) | - | - | 0.73 | 0.49 |
| 心脑血管(%) | 1.85 | 2.06 | 3.28 | 3.04 |
| 原料药及专利技术(%) | - | - | 25.91 | 24.25 |
| 肿瘤止吐(%) | 7.48 | 5.91 | 10.78 | 9.16 |
| 服务收入(%) | 10.36 | 7.13 | - | - |
| 原料药(%) | 15.10 | 12.58 | - | - |
| 其他主营业务(%) | - | - | - | 13.55 |
| 其他业务(%) | - | - | - | 0.01 |
| 其他产品(%) | 12.01 | 15.35 | 14.29 | 13.55 |